Fall 2026

Copy Intern

Posted on 7/31/2026

BGBx

BGBx

501-1,000 employees

Healthcare consultancy translating science into stories

No salary listed

New York, NY, USA

In Person

Category
Content & Writing (1)

Get referred to BGBx

See people who can refer or advise you

Requirements
  • The internship must be completed for academic credit only.
  • Candidates must be graduating in 2027 or 2028 with a Bachelor's or Master's degree in a writing-focused discipline such as English, Creative Writing, Journalism, Literature, Marketing, or Advertising.
  • Candidates should have a strong career interest in healthcare communications, advertising, life sciences, and medicine.
  • Candidates should take initiative, think quickly, and work successfully in a team-based environment.
  • Candidates must have a portfolio of writing samples ready for review.
Responsibilities
  • Collaborate with the Account Intern and Art Intern.
  • Develop creative concepts for brand campaigns or programs.
  • Design and execute materials across channels.
  • Participate in tactical brainstorming.
  • Assist with active projects in development.
  • Shadow Copy team members to learn about creative and project briefs and timelines.
  • Present creative ideas to the internal team.
  • Complete intern team assignments, an independent study project, and a final presentation.
  • Produce a project from kickoff through launch in collaboration with staff and interns from other disciplines.
  • Work on additional copy projects as required by the agency's deliverables.
  • Conduct research and develop presentation skills.
Desired Qualifications
  • A strong career interest in healthcare communications, advertising, life sciences, and medicine.
  • A self-starter attitude, initiative, and the ability to think quickly.
  • Experience interacting with people and working successfully in a team-based environment.
  • Enthusiasm and a strong work ethic to compensate for limited experience.
  • A portfolio of writing samples ready for review.

BGBx is a healthcare consultancy that helps pharmaceutical, biotech, and medical device companies turn scientific advances into practical, credible brand stories and strategies. Its services include medical communications to explain science clearly, market access planning to help products reach patients, and payer strategy to work with insurance decision-makers. The work is done by a team that combines clinical knowledge, academic insight, and industry experience, and is delivered through project-based engagements that aim for real-time, real-world impact. Unlike firms that rely on generic marketing, BGBx differentiates itself with a strong, multidisciplinary medical team and a clear focus on translating science into strategies that improve access and outcomes. The company’s goal is to help clients communicate complex science effectively while shaping reimbursement and market access to bring new therapies and devices to patients more efficiently.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

New York City, New York

Founded

2014

Get referred to BGBx

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Broader rebrand supports larger bundled accounts across the product lifecycle.
  • Payer communications and market access remain strong, high-value consulting niches.
  • AI and analytics capabilities can improve commercialization and strategy delivery.

What critics are saying

  • Large pharma clients are internalizing commercial and market-access work.
  • Generic commercial-solutions positioning weakens pricing power and brand clarity.
  • Compliance mistakes in promotional or payer communications damage trust quickly.

What makes BGBx unique

  • Independent commercial solutions partner across consulting and communications.
  • Combines science, creativity, data, technology, and digital capabilities.
  • Runs consulting, payer, advertising, and medical communications under one roof.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

4%

1 year growth

4%

2 year growth

5%
GlobeNewswire
Jan 7th, 2026
BGB Group acquires Hayden Consulting Group to expand market access expertise

BGB Group, a commercial solutions company for biopharmaceutical firms, has acquired Hayden Consulting Group, a market access and patient services consultancy. Financial terms were not disclosed. Hayden specialises in resolving complex payer, reimbursement and affordability challenges for global pharmaceutical brands. The acquisition combines Hayden's market access expertise with BGB's strategic advisory services, which span commercial due diligence, new product planning and go-to-market strategies. Hayden will continue to be led by co-founders Jamie Sidore and David MacDougall, becoming part of BGB's strategic advisory practice headed by Hilary Gentile. The combined entity aims to provide clients with integrated solutions across the full brand lifecycle, from early planning through commercialisation.

CityBiz
Nov 19th, 2024
BGB Group Appoints David Coman as Chief Executive Officer

BGB Group appoints David Coman as Chief Executive Officer.

Haymarket Media
Jun 21st, 2024
BGB Group's new creative chief Chris Palmer on AI's growth potential

BGB Group recently hired Chris Palmer as its new chief creative officer, who joined from Havas Life New York.

O'Dwyer's
Feb 28th, 2024
On the Move: APCO's Camarco Unit Names Cohen Tech Leader

Kuzel comes to imre from BGB Group, where she was EVP data, analytics and customer experience.

Business Wire
Feb 1st, 2024
Bgb Group Announces Partnership With Scrum50 To Deliver High-Impact, Consumer-Centric Creative To Healthcare Clients

NEW YORK--(BUSINESS WIRE)--BGB Group (BGB), an award-winning healthcare commercialization and communications company headquartered in New York City with offices in Washington DC, Boston, and London, today announced a strategic partnership with Scrum50 (S50), a dynamic, agile-first creative agency based in South Norwalk, CT. This collaboration marks a transformative alliance, the next phase of BGB’s expertise enhancement aimed at remaining ahead of biopharma’s biggest challenges. The teams are set to redefine creativity and impact in the healthcare sector. S50 will continue to operate independently across all industry sectors. “We are excited to formalize our partnership with S50,” noted Greg Passaretti, Founding Partner of BGB Group. “We’ve been working together for nearly a year, and we realized that there’s much more that we can accomplish for a marketplace in need of broader creative and engagement solutions.”